These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14502471)

  • 21. 3D-QSAR studies of farnesyltransferase inhibitors: a comparative molecular field analysis approach.
    Puntambekar D; Giridhar R; Yadav MR
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1821-7. PubMed ID: 16455255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional QSAR of HPPD inhibitors, PSA inhibitors, and anxiolytic agents: effect of tautomerism on the CoMFA models.
    Zou JW; Luo CC; Zhang HX; Liu HC; Jiang YJ; Yu QS
    J Mol Graph Model; 2007 Sep; 26(2):494-504. PubMed ID: 17418602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD; Hamza A; Liu J; Zhan CG
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling ligand-receptor interaction for some MHC class II HLA-DR4 peptide mimetic inhibitors using several molecular docking and 3D QSAR techniques.
    Wei HY; Tsai KC; Lin TH
    J Chem Inf Model; 2005; 45(5):1343-51. PubMed ID: 16180911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Broad-based quantitative structure-activity relationship modeling of potency and selectivity of farnesyltransferase inhibitors using a Bayesian regularized neural network.
    Polley MJ; Winkler DA; Burden FR
    J Med Chem; 2004 Dec; 47(25):6230-8. PubMed ID: 15566293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elucidating inhibitory models of the inhibitors of epidermal growth factor receptor by docking and 3D-QSAR.
    Chen G; Luo X; Zhu W; Luo C; Liu H; Puah CM; Chen K; Jiang H
    Bioorg Med Chem; 2004 May; 12(9):2409-17. PubMed ID: 15080937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
    Deng Z; Chuaqui C; Singh J
    J Med Chem; 2004 Jan; 47(2):337-44. PubMed ID: 14711306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacophore identification and validation study of CK2 inhibitors using CoMFA/CoMSIA.
    Morshed MN; Muddassar M; Pasha FA; Cho SJ
    Chem Biol Drug Des; 2009 Aug; 74(2):148-58. PubMed ID: 19563463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D-QSAR and molecular docking studies of benzaldehyde thiosemicarbazone, benzaldehyde, benzoic acid, and their derivatives as phenoloxidase inhibitors.
    Xue CB; Zhang L; Luo WC; Xie XY; Jiang L; Xiao T
    Bioorg Med Chem; 2007 Mar; 15(5):2006-15. PubMed ID: 17258462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling the activity of furin inhibitors using artificial neural network.
    Worachartcheewan A; Nantasenamat C; Naenna T; Isarankura-Na-Ayudhya C; Prachayasittikul V
    Eur J Med Chem; 2009 Apr; 44(4):1664-73. PubMed ID: 18977558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-organizing neural network for modeling 3D QSAR of colchicinoids.
    Polański J
    Acta Biochim Pol; 2000; 47(1):37-45. PubMed ID: 10961676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors.
    Korhonen LE; Rahnasto M; Mähönen NJ; Wittekindt C; Poso A; Juvonen RO; Raunio H
    J Med Chem; 2005 Jun; 48(11):3808-15. PubMed ID: 15916432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the antitumor activity of novel hydroxysemicarbazide derivatives as ribonucleotide reductase inhibitors using CoMFA and CoMSIA.
    Raichurkar AV; Kulkarni VM
    J Med Chem; 2003 Oct; 46(21):4419-27. PubMed ID: 14521406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular docking and 3D-QSAR studies of Yersinia protein tyrosine phosphatase YopH inhibitors.
    Hu X; Stebbins CE
    Bioorg Med Chem; 2005 Feb; 13(4):1101-9. PubMed ID: 15670918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 2. Applications.
    So SS; Karplus M
    J Med Chem; 1997 Dec; 40(26):4360-71. PubMed ID: 9435905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3D-QSAR analysis on benzazole derivatives as eukaryotic topoisomerase II inhibitors by using comparative molecular field analysis method.
    Temiz-Arpaci O; Tekiner-Gulbas B; Yildiz I; Aki-Sener E; Yalcin I
    Bioorg Med Chem; 2005 Dec; 13(23):6354-9. PubMed ID: 15993083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
    Mohr JA; Jain BJ; Obermayer K
    J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.